THE SAFETY AND EFFICACY OF CONVERSION FROM CALCINEURIN INHIBITORS TO mTOR INHIBITORS IN STABLE KIDNEY TRANSPLANT RECIPIENTS

被引：0
|
作者：
Asanga, Abeyaratne [1 ]
Michael, Collins [1 ]
Kym, Bannister [1 ]
Graeme, Russ [1 ]
机构：
[1] Royal Adelaide Hosp, Renal & Transplantat Unit, Cent No Adelaide Renal & Transplantat Serv, Adelaide, SA, Australia
来源：
IMMUNOLOGY AND CELL BIOLOGY | 2012年 / 90卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：A1 / A1
页数：1
相关论文
共 50 条
  • [1] Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients
    Yildiz, A.
    Cavusoglu, M.
    Adin, S.
    Caliskan, Y.
    Ozkok, A.
    Tasci, H.
    Deniz, G.
    Sariyar, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [2] CONVERSION FROM CALCINEURIN INHIBITORS TO mTOR INHIBITORS BY PROTOCOL 6-18 MONTHS POST TRANSPLANTATION IN STABLE KIDNEY TRANSPLANT RECIPIENTS: A CASE SERIES
    Collins, M.
    Russ, G.
    [J]. NEPHROLOGY, 2008, 13 : A113 - A113
  • [3] Efficacy and Safety of Early Mammalian Target of Rapamycin Inhibitors with Minimization of Calcineurin Inhibitors in Kidney Transplant Recipients
    Nakamura, Yuki
    Yokoyama, Takayoshi
    Kihara, Yu
    Konno, Osamu
    Iwamoto, Hitoshi
    [J]. TRANSPLANTATION, 2018, 102 : S464 - S464
  • [4] Conversion from calcineurin inhibitors to everolimus in kidney transplant recipients with malignant neoplasia
    Fernandez, A.
    Marcen, R.
    Pascual, J.
    Galeano, C.
    Ocana, J.
    Arellano, E. M.
    Alfaro, C.
    Villafruela, J. J.
    Burgos, F. J.
    Ortuno, J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2453 - 2455
  • [5] Conversion from calcineurin inhibitors to mTOR inhibitors
    Bodziak, Kenneth A.
    Hrick, Donald E.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2007, 12 (04) : 351 - 356
  • [6] Conversion From Calcineurin Inhibitors to Sirolimus in Kidney Transplant Recipients: A Retrospective Cohort Study
    Cardinal, H.
    Froidure, A.
    Dandavino, R.
    Daloze, P.
    Hebert, M. J.
    Colette, S.
    Boucher, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (08) : 3308 - 3310
  • [7] Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors
    Huesing, Anna
    Schmidt, Martina
    Cicinnati, Vito R.
    Koch, Raphael
    Thoelking, Gerold
    Stella, Jaqueline
    Heinzow, Hauke
    Schmidt, Hartmut H.
    Kabar, Iyad
    [J]. ANNALS OF TRANSPLANTATION, 2015, 20
  • [8] The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant
    Boswell, A
    Evans, L
    Rigg, K
    Shehata, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 884 - 885
  • [9] Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?
    Gonzalez-Vilchez, F.
    Vazquez de Prada, J. A.
    Paniagua, M. J.
    Gomez-Bueno, M.
    Arizon, J. M.
    Almenar, L.
    Roig, E.
    Delgado, J.
    Lambert, L.
    Perez-Villa, F.
    Sanz-Julve, M. L.
    Crespo-Leiro, M.
    Segovia, J.
    Lopez-Granados, A.
    Martinez-Dolz, L.
    Mirabet, S.
    Escribano, P.
    Diaz-Molina, B.
    Farrero, M.
    Blasco, T.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 171 (01) : 15 - 23
  • [10] Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
    Yu, Ji Hyun
    Kim, Kyoung Woon
    Kim, Bo-Mi
    Chung, Byung Ha
    Cho, Mi-La
    Choi, Bum Soon
    Park, Cheol Whee
    Kim, Yong-Soo
    Yang, Chul Woo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (03): : 552 - 559
12345